TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Zhao, Liqin;Qu, Xiaofei;Wu, Zhenhua;Li, Yuehua;Zhang, Xiaowei*;...

通讯作者：

Zhang, Xiaowei;Guo, WeiJian

作者机构：

[Zhao, Liqin; Zhang, Xiaowei; Guo, WeiJian; Wu, Zhenhua] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.

[Qu, Xiaofei; Zhao, Liqin; Zhang, Xiaowei; Guo, WeiJian; Wu, Zhenhua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.

[Qu, Xiaofei] Fudan Univ, Canc Inst, Shanghai Canc Ctr, Shanghai, Peoples R China.

[Li, Yuehua] Univ South China, Dept Med Oncol, Affiliated Hosp 1, Hengyang, Hunan, Peoples R China.

通讯机构：

[Zhang, XW; Guo, WJ] F

Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.

Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.

语种：

英文

关键词：

TP53;immunotherapy;non-small cell lung cancer;somatic mutation;tumor mutation burden

期刊：

AGING-US

ISSN：

1945-4589

年：

2020

卷：

期：

页码：

14556-14568

DOI：

10.18632/aging.103502

基金类别：

This work was financially supported by the Natural Science Foundation of China (Grant No. 81871948).

机构署名：

本校为其他机构

院系归属：

医学院

摘要：

In this study, we investigated the association between TP53 somatic mutations and immunotherapeutic outcomes in non-small cell lung cancer (NSCLC) patients. Kaplan-Meier survival curve analysis of the MSK-IMPACT cohort of 350 NSCLC patients shows that overall survival (OS) is significantly lower for patients with truncating TP53 mutations than those with wild-type TP53 (OS: 9 months vs. 14 months; P=0.019). Multivariate analysis shows that truncating TP53 mutations are an independent predictor of immunotherapeutic outcomes. Moreover, among NSCL...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问